James D. Petrilla
Geschäftsführer bei TriPath Oncology, Inc.
Profil
James D.
Petrilla is Senior Vice President of Commercial Operations for TriPath Oncology, Inc. and TriPath Imaging, Inc. Prior to joining TriPath in January, 2006, he was President and Chief Executive Officer of StemCo Biomedical, Inc., Vice President and General Manager of the Biovail Corp., Vice President of Global Brand Champion, General Manager of Anti-Virals Europe, Vice President of National Accounts and Managed Care Sales-East Area for the Bristol-Myers Squibb Co. Mr. Petrilla received a degree from the United States Naval Academy.
Aktive Positionen von James D. Petrilla
| Unternehmen | Position | Beginn |
|---|---|---|
TriPath Oncology, Inc.
 TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Geschäftsführer | 19.07.2004 |
Ehemalige bekannte Positionen von James D. Petrilla
| Unternehmen | Position | Ende |
|---|---|---|
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Stemco Biomedical, Inc. | Präsident | - |
Ausbildung von James D. Petrilla
| United States Naval Academy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 3 |
|---|---|
TriPath Oncology, Inc.
TriPath Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services TriPath Oncology, Inc. develops and commercializes molecular diagnostics and pharmacogenomic tests for cancer. It diagnoses and tests for malignant melanoma and cancer of the prostate, colon, breast, ovary, and cervix. The company was founded on July 31, 2001 and is headquartered in Durham, NC. | Commercial Services |
| Stemco Biomedical, Inc. | |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
